Suchergebnisse - "Lim, Kian-Huat"

PubPharm (131)

1

OPA1 ANTISENSE OLIGOMERS FOR TREATMENT OF CONDITIONS AND DISEASES

enthalten in: Europäisches Patentamt | 2024

von AZNAREZ ISABEL | LIM KIAN HUAT | KACH JACOB

2

Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancer

enthalten in: Nature communications | 2024

von Bulle, A. | Liu, P. | Seehra, K. | +24

3

Chemokine Receptor 2 Targeted PET/CT Imaging Distant Metastases in Pancreatic Ductal Adenocarcinoma

enthalten in: ACS pharmacology & translational science | 2024

von Zhang, X. | Detering, L. | Heo, G. | +15

4

PLADIENOLIDE PYRIDINE COMPOUNDS AND METHODS OF USE

enthalten in: Europäisches Patentamt | 2024

von KEANEY GREGG F | WANG JOHN | GERARD BAUDOUIN | +20

5

Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma

enthalten in: Cancer research | 2023

von Wu, Y. | Chen, S. | Yang, X. | +36

6

A Pilot Study of Paricalcitol plus Nanoliposomal Irinotecan and 5-FU/LV in Advanced Pancreatic Cancer Patients after Progression on Gemcitabine-Based Therapy

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Grierson, P. | Suresh, R. | Tan, B. | +10

7

METHODS AND COMPOSITIONS FOR IMAGING AND TREATING CANCER

enthalten in: Europäisches Patentamt | 2023

von LIU YONGJIAN | ZHANG XIAOHUI | LIM KIAN-HUAT

8

Correction : Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: a Phase I Dose Escalation and Expansion Study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Wang-Gillam, A. | Lim, K. | McWilliams, R. | +21

ErratumFor: Clin Cancer Res. 2022 Dec 15;28(24):5254-5262. - PMID 36228156

9

High-dimensional deconstruction of pancreatic cancer identifies tumor microenvironmental and developmental stemness features that predict survival

enthalten in: NPJ precision oncology | 2023

von Storrs, E. | Chati, P. | Usmani, A. | +27

10

Splice variants associated with neomorphic SF3B1 mutants

enthalten in: Europäisches Patentamt | 2023

von YU LIHUA | LIM KIAN HUAT | FEALA JACOB D | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]